000 | 01674 a2200445 4500 | ||
---|---|---|---|
005 | 20250512002112.0 | ||
264 | 0 | _c19880620 | |
008 | 198806s 0 0 eng d | ||
022 | _a0090-8258 | ||
024 | 7 |
_a10.1016/0090-8258(88)90038-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeiner, S A | |
245 | 0 | 0 |
_aA phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. _h[electronic resource] |
260 |
_bGynecologic oncology _cMay 1988 |
||
300 |
_a1-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMitomycin |
650 | 0 | 4 |
_aMitomycins _xadministration & dosage |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aAristizabal, S | |
700 | 1 | _aAlberts, D S | |
700 | 1 | _aSurwit, E A | |
700 | 1 | _aDeatherage-Deuser, K | |
773 | 0 |
_tGynecologic oncology _gvol. 30 _gno. 1 _gp. 1-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-8258(88)90038-8 _zAvailable from publisher's website |
999 |
_c2458800 _d2458800 |